Skip to content

Neural mechanisms and intervention study of interpersonal coordination deficits in schizophrenia through high-definition transcranial alternating current stimulation

Neural mechanisms and intervention study of interpersonal coordination deficits in schizophrenia through high-definition transcranial alternating current stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100113
Enrollment
Unknown
Registered
2025-04-02
Start date
2025-04-07
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

Experimental group:HD-tACS stimulation with a GAMA frequency while the patient-healthy dyads performing an interpersonal paradigm (a joint finger tapping task).
Resting control group:HD-tACS stimulation scheme as the experimental group but without a simultaneous behavioral task.
Active control group:HD-tACS stimulation scheme as the experimental group but with a different frequency (theta).
Sham control group:the HD-tACS stimulation is on during the first minute of initiation and the last minute of termination while the participants performing the joint finger tapping task.
Behavioral training group:Intervention only based on the joint finger tapping task.

Sponsors

Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients with schizophrenia: 1.Diagnosed as schizophrenia according to DSM-5 criteria, screened with the Structured Clinical Interview for DSM-5; 2. Possessing at least a junior high school education level (or equivalent); 3. Age 18-50, right handedness; 4. Illness duration =10years; 5. Anti-psychotic naïve or on stable medication with no more than two types of anti-psychotics within at least 2 weeks; 6. No administration of sedatives, stimulants, alcohol, strong tea, coffee, or any psychoactive substances on the day before the experiment. Healthy participants: 1. No history of psychiatric disorders; 2. Possessing at least a junior high school education level (or equivalent); 3. Age 18-50, right handedness; 4. No administration of sedatives, stimulants, alcohol, strong tea, coffee, or any psychoactive substances on the day before the experiment.

Exclusion criteria

Exclusion criteria: Patients with schizophrenia: 1.With a history of head trauma with loss of consciousness, mental retardation, active substance dependence or abuse; have transient ischemic attack, migraine, syncope or other conditions that may affect brain function. 2.Presence of brain tumors, diabetes mellitus, hypertension, cardiovascular diseases, or other severe medical conditions (e.g., infections, allergies). 3.With a history of neurological disorder (including but not limited to epilepsy, multiple sclerosis, etc.). 4.Presence of metallic implants in the cranium or other devices susceptible to external electrical interference (e.g., cranial fixation devices). 5.Patients evaluated as moderate to high risk on the Suicide Risk Assessment Scale (NGASR), had a significant suicidal ideation in the past 12 months, or those deemed to present suicide and violent behavior risks based on clinicians' assessments. 6.Individuals with a history of violent behavior within the past 12 months, those exhibiting highly aggressive tendencies as assessed by the Modified Outcomes Assessment Scale (MOAS) (weighted total score >=4), or those considered potentially threatening to others according to clinical evaluations. 7. Comorbidity with other psychiatric disorders, such as comorbid depressive disorder or bipolar disorder. Healthy participants: 1. With a history of head trauma with loss of consciousness, mental retardation, active substance dependence or abuse; have transient ischemic attack, migraine, syncope or other conditions that may affect brain function. 2. Presence of brain tumors, diabetes mellitus, hypertension, cardiovascular diseases, or other severe medical conditions (e.g., infections, allergies). 3. With a history of neurological disorder (including but not limited to epilepsy, multiple sclerosis, etc.). 4. Presence of metallic implants in the cranium or other devices susceptible to external electrical interference (e.g., cranial fixation devices).

Design outcomes

Primary

MeasureTime frame
Intra- and Inter-brain synchrony;Positive and Negative Symptoms;Clinical Global Impression ;Personal and Social Performance;World Health Organization Quality of Life;Cognitive function;Interpersonal behavioral synchronization;

Secondary

MeasureTime frame
Depressive symptoms;

Countries

China

Contacts

Public ContactJi Chen

Global Institude of Future Technology, Shanghai Jiao Tong University

chen.ji@sjtu.edu.cn+86 137 3810 3217

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026